Abstract

The growing need of dietary supplements, self- medication and patients’ non-disclosure of herbal supplements use to doctors, the possible occurrence of adverse effects and the interaction with prescribed and over the counter drugs are among the reasons that require more rigorous assessment of the usefulness and safety of herbal supplements in order to best integrate them into common regimens. Lax control of production and distribution, and the lack of uniform legislation determine the need for changes in the regulation and harmonization of legislation in this area. Developing an appropriate postmarketing quality, efficacy and safety surveillance program will be a useful step, allowing the generation of important and relevant information for optimizing the risk - benefit ratio.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.